Northwest BioTherapeutics, Inc. (NWBO) Advances Toward Commencement of Phase III Brain Cancer Trial in Europe
Today, Northwest Biotherapeutics announced that it has named a leading international contract research organization (CRO) to manage its 312-patient Phase…